rs147841245
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_005751.5(AKAP9):c.6896A>G(p.Glu2299Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000183 in 1,613,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E2299Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Publications
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
- long QT syndrome 11Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AKAP9 | NM_005751.5 | c.6896A>G | p.Glu2299Gly | missense_variant | Exon 30 of 50 | ENST00000356239.8 | NP_005742.4 | |
| AKAP9 | NM_147185.3 | c.6872A>G | p.Glu2291Gly | missense_variant | Exon 30 of 50 | NP_671714.1 | ||
| AKAP9 | NM_001379277.1 | c.1541A>G | p.Glu514Gly | missense_variant | Exon 9 of 29 | NP_001366206.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152152Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000120 AC: 30AN: 250718 AF XY: 0.000155 show subpopulations
GnomAD4 exome AF: 0.000193 AC: 282AN: 1461518Hom.: 0 Cov.: 31 AF XY: 0.000191 AC XY: 139AN XY: 727076 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152152Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74346 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Long QT syndrome 11 Uncertain:2
The p.Glu2299Gly variant (rs147841245) has not been reported in the medical literature nor has it been previously identified in our laboratory; however, it is listed in the ClinVar database as a variant of uncertain significance (Variation ID: 360836). It is listed in the Genome Aggregation Database (gnomAD) browser with a frequency in non-Finnish Europeans of 0.021% (identified in 27 out of 126,200 chromosomes). The glutamic acid at codon 2299 is highly conserved considering 11 species up to Cow (Alamut software v2.9), although computational analyses return mixed results regarding the effect of this variant on AKAP9 protein structure/function (SIFT: damaging, PolyPhen2: benign, and Mutation Taster: disease causing). Therefore, based on the available information, the clinical significance of the p.Glu2299Gly variant cannot be determined with certainty. -
- -
Congenital long QT syndrome Uncertain:1
- -
Long QT syndrome Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 2299 of the AKAP9 protein (p.Glu2299Gly). This variant is present in population databases (rs147841245, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with AKAP9-related conditions. ClinVar contains an entry for this variant (Variation ID: 360836). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at